Loading cancer entity…
Loading cancer entity…
Clinical trials
218 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02298270 | Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype | completed | N/A | 65 | Massachusetts General HospitalOTHER | 1 | Jun 23, 2016 | clinicaltrials |
| NCT02275325 | Preoperative Vestibular Rehabilitation Effectiveness After Vestibular Schwannoma Surgery(ReveSTAN) | unknown | N/A | 50 | Central Hospital, Nancy, FranceOTHER | 1 | Jun 21, 2016 | clinicaltrials |
| NCT00720174 | Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | May 17, 2016 | clinicaltrials |
| NCT01567046 | Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas | completed | — | 70 | Children's Oncology GroupNETWORK | 1 | May 17, 2016 | clinicaltrials |
| NCT00973739 | Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors | completed | Phase 2 | 21 | NYU Langone HealthOTHER | 1 | Mar 22, 2016 | clinicaltrials |
| NCT00837148 | Sorafenib and Dacarbazine in Soft Tissue Sarcoma | completed | Phase 2 | 37 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 20, 2015 | clinicaltrials |
| NCT01119599 | RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma | completed | Phase 1 | 22 | National Cancer Institute (NCI)NIH | 1 | Sep 29, 2015 | clinicaltrials |
| NCT00411216 | Recovery of Visual Acuity in People With Vestibular Deficits | completed | N/A | 23 | Emory UniversityOTHER | 1 | Aug 7, 2015 | clinicaltrials |
| NCT00716469 | Phase I Clinical Study of the Safety of Photodynamic Therapy (PDT) Using LS11 in Children With Plexiform Neurofibromas(PDT) | terminated | Phase 1 | 7 | Children's Hospital of PhiladelphiaOTHER | 1 | Apr 15, 2015 | clinicaltrials |
| NCT01412892 | Use of RAD001 as Monotherapy in the Treatment of Neurofibromatosis 1 Related Internal Plexiform Neurofibromas(NFitor) | completed | Phase 2 | 30 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Nov 14, 2014 | clinicaltrials |
| NCT00245102 | Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma | completed | Phase 2 | 147 | National Cancer Institute (NCI)NIH | 1 | May 23, 2014 | clinicaltrials |
| NCT01951365 | Assessment of Volumetric Growth Rates of Spinal Intradural Extramedullary Schwannoma | completed | — | 56 | Seoul National University HospitalOTHER | 1 | Sep 26, 2013 | clinicaltrials |
| NCT01777451 | Whole Body Magnetic Resonance Imaging With Diffusion Weighted Imaging : Potential Role in Neurofibromatosis(NEFIMAR) | unknown | — | 30 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jan 28, 2013 | clinicaltrials |
| NCT01743248 | Vestibular Schwannoma and Psychological Factors | unknown | — | 50 | Central Hospital, Nancy, FranceOTHER | 1 | Dec 6, 2012 | clinicaltrials |
| NCT00427583 | Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors | terminated | Phase 2 / Phase 3 | 11 | Novartis PharmaceuticalsINDUSTRY | 1 | Aug 7, 2012 | clinicaltrials |
| NCT01031901 | Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1) | completed | Phase 1 | 52 | The University of Texas Health Science Center, HoustonOTHER | 1 | Feb 27, 2012 | clinicaltrials |
| NCT01449604 | Stereotactic Radiation in Vestibular Schwannoma | unknown | Phase 3 | 200 | Ramathibodi HospitalOTHER | 0 | Oct 10, 2011 | clinicaltrials |
| NCT00004483 | NF2 Natural History Consortium | unknown | — | 100 | House Ear InstituteOTHER | 1 | Sep 29, 2005 | clinicaltrials |
Data updated 23 days agoSource updated Jun 23, 2016source: clinicaltrials